Dexmedetomidine Ameliorates Sleep Deprivation-Induced Depressive Behaviors in Mice
2
조회
0
다운로드
7
인용
0
참고문헌
키워드
초록
Purpose: Sleep deprivation induces depressive symptoms. Dexmedetomidine is a α2-adrenoreceptor agonist and this drug possesses sedative, anxiolytic, analgesic, and anesthetic-sparing effect. In this study, the action of dexmedetomidine on sleep deprivation-induced depressive behaviors was investigated using mice. Methods: For the inducing of sleep deprivation, the mice were placed inside a water cage containing 15 platforms and filled with water up to 1 cm below the platform surface for 7 days. One day after sleep deprivation, dexmedetomidine at the respective dosage (0.5, 1, and 2 μg/kg) was intraperitoneally treated into the mice, one time per a day during 6 days. Then, forced swimming test and tail suspension test were conducted. Immunohistochemistry for tyrosine hydroxylase (TH), 5-hydroxytryptamine (5-HT; serotonin), tryptophan hydroxylase (TPH) and western blot for D1 dopamine receptor were also performed. Results: Sleep deprivation increased the immobility latency in the forced swimming test and tail suspension test. The expressions of TPH, 5-HT, and D1 dopamine receptor were decreased, whereas, TH expression was increased by sleep deprivation. Dexmedetomidine decreased the immobility latency and increased the expressions of TPH, 5-HT, and D1 dopamine receptor, whereas, HT expression was decreased by dexmedetomidine treatment. Conclusions: In our results, dexmedetomidine alleviated sleep deprivation-induced depressive behaviors by increasing 5-HT synthesis and by decreasing dopamine production with up-regulation of D1 dopamine receptor.
Abstract
Purpose: Sleep deprivation induces depressive symptoms. Dexmedetomidine is a α2-adrenoreceptor agonist and this drug possesses sedative, anxiolytic, analgesic, and anesthetic-sparing effect. In this study, the action of dexmedetomidine on sleep deprivation-induced depressive behaviors was investigated using mice. Methods: For the inducing of sleep deprivation, the mice were placed inside a water cage containing 15 platforms and filled with water up to 1 cm below the platform surface for 7 days. One day after sleep deprivation, dexmedetomidine at the respective dosage (0.5, 1, and 2 μg/kg) was intraperitoneally treated into the mice, one time per a day during 6 days. Then, forced swimming test and tail suspension test were conducted. Immunohistochemistry for tyrosine hydroxylase (TH), 5-hydroxytryptamine (5-HT; serotonin), tryptophan hydroxylase (TPH) and western blot for D1 dopamine receptor were also performed. Results: Sleep deprivation increased the immobility latency in the forced swimming test and tail suspension test. The expressions of TPH, 5-HT, and D1 dopamine receptor were decreased, whereas, TH expression was increased by sleep deprivation. Dexmedetomidine decreased the immobility latency and increased the expressions of TPH, 5-HT, and D1 dopamine receptor, whereas, HT expression was decreased by dexmedetomidine treatment. Conclusions: In our results, dexmedetomidine alleviated sleep deprivation-induced depressive behaviors by increasing 5-HT synthesis and by decreasing dopamine production with up-regulation of D1 dopamine receptor.
참고문헌 (32)
- Veasey S, "Sleep loss and fatigue in residency training: a reappraisal", JAMA, 288, pp.1116~1124 (2002)
- Adrien J, "Neurobiological bases for the relation between sleep and depression", Sleep Med Rev, 6, pp.341~351 (2002)
- Baek SS, "Effects of postnatal treadmill exercise on apoptotic neuronal cell death and cell proliferation of maternal-separated rat pups", Brain Dev, 34, pp.45~56 (2012)
- 노주환, "Treadmill exercise ameliorates intracerebral hemorrhage-induced depression in rats", Journal of exercise rehabilitation, 12(4), pp.299~307 (2016), 한국운동재활학회
- Sung YH, "Depression-like state in maternal rats induced by repeated separation of pups is accompanied by a decrease of cell proliferation and an increase of apoptosis in the hippocampus", Neurosci Lett, 470, pp.86~90 (2010)
- Haavik J, "Tyrosine hydroxylase and Parkinson’s disease", Mol Neurobiol, 16, pp.285~309 (1998)
- Rye DB, "Parkinson’s disease and RLS: the dopaminergic bridge", Sleep Med, 5, pp.317~328 (2004)
- Beaulieu JM, "The physiology, signaling, and pharmacology of dopamine receptors", Pharmacol Rev, 63, pp.182~217 (2011)
- Azogu I, "Acute sleep deprivation enhances avoidance learning and spatial memory and induces delayed alterations in neurochemical expression of GR, TH, DRD1, pCREB and Ki67 in rats", Behav Brain Res, 279, pp.177~190 (2015)
- Vallone D, "Structure and function of dopamine receptors", Neurosci Biobehav Rev, 24, pp.125~132 (2000)
- Deransart C, "Upregulation of D3 dopaminergic receptor mRNA in the core of the nucleus accumbens accompanies the development of seizures in a genetic model of absence-epilepsy in the rat", Brain Res Mol Brain Res, 94, pp.166~177 (2001)
- Amiri S, "Involvement of D1 and D2 dopamine receptors in the anti-depressant-like effects of selegiline in maternal separation model of mouse", Physiol Behav, 163, pp.107~114 (2016)
- Panzer O, "Pharmacology of sedative-analgesic agents: dexmedetomidine, remifentanil, ketamine, volatile anesthetics, and the role of peripheral Mu antagonists", Anesthesiol Clin, 29, pp.587~605 (2011)
- Choi IY, "Dexmedetomidine alleviates cerebral ischemia-induced short-term memory impairment by inhibiting the expression of apoptosis-related molecules in the hippocampus of gerbils", Exp Ther Med, 13, pp.107~116 (2017)
- Hwang L, "Dexmedetomidine ameliorates intracerebral hemorrhage-induced memory impairment by inhibiting apoptosis and enhancing brain-derived neurotrophic factor expression in the rat hippocampus", Int J Mol Med, 31, pp.1047~1056 (2013)
- 한진희, "Dexmedetomidine, α2-adrenoceptor agonist, does not induce apoptosis in the brachial plexus of rats", Animal Cells and Systems, 18(6), pp.407~415 (2014), 한국통합생물학회[DOI]
- 박제훈, "Dexmedetomidine Oral Mucosa Patch for Sedation Suppresses Apoptosis in Hippocampus of Normal Rats", International Neurourology Journal, 21, pp.39~47 (2017), 대한배뇨장애요실금학회
- Novati A, "Chronically restricted sleep leads to depression-like changes in neurotransmitter receptor sensitivity and neuroendocrine stress reactivity in rats", Sleep, 31, pp.1579~1585 (2008)
- Lim MM, "Sleep deprivation differentially affects dopamine receptor subtypes in mouse striatum", Neuroreport, 22, pp.489~493 (2011)
- 지은상, "Treadmill exercise ameliorates depressive symptoms through increasing serotonin expression in postpartum depression rats", Journal of exercise rehabilitation, 13(2), pp.130~136 (2017), 한국운동재활학회
- Holmes A, "Phenotypic assessment of galanin overexpressing and galanin receptor R1 knockout mice in the tail suspension test for depressionrelated behavior", Psychopharmacology (Berl), 178, pp.276~285 (2005)
- Rosa PB, "Folic acid prevents depressive-like behavior induced by chronic corticosterone treatment in mice", Pharmacol Biochem Behav, 127, pp.1~6 (2014)
- Ko IG, "Swimming exercise alleviates the symptoms of attention-deficit hyperactivity disorder in spontaneous hypertensive rats", Mol Med Rep, 8, pp.393~400 (2013)
- Daniele TM, "Effects of exercise on depressive behavior and striatal levels of norepinephrine, serotonin and their metabolites in sleep-deprived mice", Behav Brain Res, 332, pp.16~22 (2017)
- de Oliveira RA, "The effect of venlafaxine on behaviour, body weight and striatal monoamine levels on sleep-deprived female rats", Pharmacol Biochem Behav, 79, pp.499~506 (2004)
- Stone EA, "Antidepressant-like action of intracerebral 6-fluoronorepinephrine, a selective full α-adrenoceptor agonist", Int J Neuropsychopharmacol, 14, pp.319~331 (2011)
- Bjorvatn B, "Effects of sleep deprivation on extracellular serotonin in hippocampus and frontal cortex of the rat", Neuroscience, 113, pp.323~330 (2002)
- Damasceno F, "Sleep deprivation affects sexual behavior and tyrosine hydroxylase (TH) levels in sexually experienced male rats", Physiol Behav, 94, pp.405~411 (2008)
- 신말순, "Treadmill exercise alleviates nigrostriatal dopaminergic loss of neurons and fibers in rotenone-induced Parkinson rats", Journal of exercise rehabilitation, 13(1), pp.30~35 (2017), 한국운동재활학회
- Whittington RA, "Dexmedetomidine-induced decreases in accumbal dopamine in the rat are partly mediated via the locus coeruleus", Anesth Analg, 10, pp.448~455 (2006)
- Oganesyan GA, "The dopaminergic nigrostriatal system in sleep deprivation in cats", Neurosci Behav Physiol, 38, pp.785~792 (2008)
- Seugnet L, "D1 receptor activation in the mushroom bodies rescues sleep-loss-induced learning impairments in Drosophila", Curr Biol, 18, pp.1110~1117 (2008)